Pharmacokinetics and biodistribution of a new anti-episialin monoclonal antibody 139H2 in ovarian-cancer-bearing nude mice

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Cancer Immunology and Immunotherapy

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/BF01742312PMID 1756536PMCID PMC11038523
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Human ovarian cancer xenografts in nude mice: Characterization and analysis of antigen expression

  1991influential reference
• Immunoscintigraphy of ovarian cancer with indium-111-labeled OV-TL 3 F(ab')2 monoclonal antibody.

  1990cited by this paper
• A phase I toxicity, pharmacology, and dosimetry trial of monoclonal antibody OKB7 in patients with non-Hodgkin's lymphoma: effects of tumor burden and antigen expression.

  1990cited by this paper
• Radiolocalization of human pancreatic tumors in athymic mice by monoclonal antibody DU-PAN 1.

  1990cited by this paper
• Biodistribution and histological localization of anti‐human colon cancer monoclonal antibody (MAb) 1A3: The influence of administered MAB dose on tumor uptake

  1989cited by this paper
• Effect of tumor mass and antigenic nature on the biodistribution of labeled monoclonal antibodies in mice.

  1989cited by this paper
• Complexity of MAM-6, an epithelial sialomucin associated with carcinomas.

  1989cited by this paper
• Biodistribution of indium-111-labeled OC 125 monoclonal antibody intraperitoneally injected into patients operated on for ovarian carcinomas.

  1989cited by this paper
• Monoclonal antibodies reactive with human breast or ovarian carcinoma: in vivo applications.

  1989cited by this paper
• Labeling of monoclonal antibodies with radionuclides.

  1989cited by this paper
• Tissue and tumor distribution of human polymorphic epithelial mucin

  1988cited by this paper
• Intracavitary use of two radiolabeled tumor-associated monoclonal antibodies.

  1988cited by this paper
• Immunospecific saturable clearance mechanisms for indium-111-labeled anti-melanoma monoclonal antibody 96.5 in humans.

  1988cited by this paper
• Improved tumor localization with increasing dose of indium-111-labeled anti-carcinoembryonic antigen monoclonal antibody ZCE-025 in metastatic colorectal cancer.

  1988cited by this paper
• Effect of antibody dose on the imaging and biodistribution of indium-111 9.2.27 anti-melanoma monoclonal antibody.

  1988cited by this paper
• Characterization of the CA 125 antigen associated with human epithelial ovarian carcinomas.

  1986cited by this paper
• Tumor size: effect on monoclonal antibody uptake in tumor models.

  1986cited by this paper
• Iodination of monoclonal antibodies for diagnosis and radiotherapy using a convenient one vial method.

  1986cited by this paper
• Determination of the immunoreactive fraction of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess.

  1984cited by this paper
• A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer.

  1983cited by this paper
• Characterization of WiDr: A human colon carcinoma cell line

  1979cited by this paper

• The Effect of Endoplasmic Reticulum Stress on Podocyte Apoptosis in Diabetic Nephropathy

  2020cites this paper
• In vivo PET assay of functional P-gp in the blood-brain barrier

  2006cites this paper
• (R)- and (S)-[11C]verapamil as PET-tracers for measuring P-glycoprotein function: in vitro and in vivo evaluation.

  2003cites this paper
• Biokinetics of the monoclonal antibodies MOv 18, OV 185 and OV 197 labelled with 125I according to the m-MeATE method or the Iodogen method in nude mice with ovarian cancer xenografts.

  1999cites this paper
• Biodistribution of 111In-labelled engineered human antibody CTM01 (hCTM01) in ovarian cancer patients: influence of prior administration of unlabelled hCTM01

  1998cites this paper
• Comparison of 131I‐labelled anti‐episialin 139H2 with cisplatin, cyclophosphamide or external‐beam radiation for anti‐tumor efficacy in human ovarian cancer xenografts

  1992cites this paper
• Influence of dose and schedule on the therapeutic efficacy of 131I‐labelled monoclonal antibody 139H2 in a human ovarian cancer xenograft model

  1992cites this paper
• Comparison of the pharmacokinetics, biodistribution and dosimetry of monoclonal antibodies OC125, OV-TL 3, and 139H2 as IgG and F(ab')2 fragments in experimental ovarian cancer.

  1992cites this paper